Albumin fused coagulation factors for non-intravenous administration in the therapy and prophylactic treatment of bleeding disorders

Details for Australian Patent Application No. 2010284977 (hide)

Owner CSL Behring GmbH

Inventors Kronthaler, Ulrich

Agent Watermark

Pub. Number AU-A-2010284977

PCT Pub. Number WO2011/020866

Priority 61/237,006 26.08.09 US; 09010699.8 20.08.09 EP

Filing date 18 August 2010

Wipo publication date 24 February 2011

International Classifications

C07K 14/745 (2006.01) Peptides having more than 20 amino acids

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 7/04 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61K 38/36 (2006.01) Medicinal preparations containing peptides - Blood coagulation or fibrinolysis factors

C07K 14/75 (2006.01) Peptides having more than 20 amino acids

C07K 14/755 (2006.01) Peptides having more than 20 amino acids

C07K 14/765 (2006.01) Peptides having more than 20 amino acids

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

Event Publications

29 March 2012 PCT application entered the National Phase

  PCT publication WO2011/020866 Priority application(s): WO2011/020866

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010284996-Disease resistant tomato plants

2010284972-Heterocyclic oxime compounds